Abstract
MUTATIONS in the gene for the visual pigment rhodopsin cause retinitis pigmentosa (RP) and congenital night blindness1,7. Inheritance of the diseases is generally autosomal dominant and about 40 different rhodopsin mutations have been documented. Although the cell death and retinal degeneration associated with RP have been suggested to result from improper folding and accumulation of the mutant proteins in rod photoreceptor cells8, this may not account for the disease in all cases. For example, RP mutations at Lys 296, site of Schiff base linkage to the retinal chromophore, result in constitutive activation of the protein in vitro9–11; that is, the mutants can catalytically activate the G protein transducin in the absence of chromophore and in the absence of light. Similarly, mutation of Ala 292 → Glu activates opsin in vitro and causes night blindness7. We show here that the mutation Gly 90 → Asp (G90D) in the second transmembrane segment of rhodopsin, which causes congenital night blindness12, also constitutively activates opsin. Furthermore, we show that Asp 90 can substitute for the Schiff base counterion, Glu 113, which is located in the third transmembrane segment of the protein. This demonstrates the proximity of Asp 90 and Lys 296 in the three-dimensional structure of rhodopsin and suggests that the constitutively activating mutations operate by a common molecular mechanism, disrupting a salt bridge between Lys 296 and the Schiff base counterion, Glu 113.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dryja, T. P. et al. Nature 343, 364–366 (1990).
Farrar, G. J. et al. Am. J. hum. Genet. 47, 941–945 (1990).
Sung, C.-H. et al. Proc. natn. Acad. Sci. U.S.A. 88, 6481–6485 (1991).
Keen, T. J. et al. Genomics 11, 199–205 (1991).
Humphries, P., Kenna, P. & Farrar, G. J. Science 256, 804–808 (1992).
Sullivan, J. M., Scott, K. M., Falls, H. F., Richards, JH. E. & Sieving, P. A. Invest. Ophthalmol. Vis. Sci. 34, 1149 (1993).
Dryja, T. P., Berson, E. L., Rao, V. R. & Oprian, D. D. Nature Genet. 4, 280–283 (1993).
Sung, C.-H., Schneider, B. G., Agarwal, N., Papermaster, D. S & Nathans, J. Proc. natn. Acad. Sci. U.S.A. 88, 8840–8844 (1991).
Robinson, P. R., Cohen, G. B., Zhukovsky, E.A. & Oprian, D. D. Neuron 9, 719–725 (1992).
Cohen, G. B., Oprian, D. D. & Robinson, P. R. Biochemistry 31, 12592–12601 (1992).
Cohen, G. B., Tang, T., Robinson, P. R. & Oprian, D. D. Biochemistry 32, 6111–6115 (1993).
Sieving, P. A., Richards, J. E., Bingham, E. L. & Naarendorp, F. Invest. Ophthalmol. Vis. Sci. 33, 1397 (1992).
Morton, R. A. & Pitt, G. A. J. Biochem. J. 59, 128–134 (1955).
Matthews, R. G., Hubbard, R., Brown, P. K. & Wald, G. J. J. gen. Physiol. 47, 215–240 (1963).
Emeis, D., Kuhn, H., Reichert, J. & Hofmann, K. P. FEBS Lett. 143, 29–34 (1982).
Zhukovsky, E. A. & Oprian, D. D. Science 246, 928–930 (1989).
Sakmar, T. P., Franke, R. R. & Khorana, H. G. Proc. natn. Acad. Sci. U.S.A. 86, 8309–8313 (1989).
Schertler, G. F. X., Villa, C. & Henderson, R. Nature 362, 770–772 (1993).
Baldwin, J. M. EMBO J. 12, 1693–1703 (1993).
Zhukovsky, E. A., Robinson, P. R. & Oprian, D. D. Science 251, 558–560 (1991).
Dratz, E. A. & Hargrave, P. A. Trends biochem. Sci. 8, 128–131 (1983).
Rando, R. R. Angew. Chem. Int. Ed. Engl. 29, 461–480 (1990).
Baylor, D. A., Nunn, B. J. & Schnapf, J. L. J. Physiol. 357, 575–607 (1984).
Noell, W. K. Vision Res. 20, 1163–1171 (1980).
Fain, G. L. & Lisman, J. E. Expl Eye Res. 57, 335–350 (1993).
Dolph, P. J. et al. Science 260, 1910–1916 (1993).
Parma, J. et al. Nature 365, 649–651 (1993).
Shenker, A. et al. Nature 365, 652–654 (1993).
Robbins, L. S. et al. Cell 72, 827–834 (1993).
Ferretti, L., Karnik, S. S., Khorana, H. G., Nassal, M. & Oprian, D. D. Proc. natn. Acad. Sci. U.S.A. 83, 599–603 (1986).
Oprian, D. D., Molday, R. S., Kaufman, R. J. & Khorana, H. G. Proc. natn. Acad. Sci. U.S.A. 84, 8874–8878 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rao, V., Cohen, G. & Oprian, D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639–642 (1994). https://doi.org/10.1038/367639a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/367639a0
This article is cited by
-
Earliest molecular events of vision revealed
Nature (2023)
-
Structural aspects of rod opsin and their implication in genetic diseases
Pflügers Archiv - European Journal of Physiology (2021)
-
Arrestin-1 engineering facilitates complex stabilization with native rhodopsin
Scientific Reports (2019)
-
Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association
Documenta Ophthalmologica (2018)
-
Why choose 9-cis retinal for therapy of congenital stationary night blindness caused by G90D rhodopsin?
Theoretical Chemistry Accounts (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.